Takeover

DLBDolby Laboratories, Inc.

Patent Owners & Lessors

Revenue
$1.3BFY2021: $1.3BFY2022: $1.3BFY2023: $1.3BFY2024: $1.3BFY2025: $1.3B
5.9% YoY
Operating margin
19.6%FY2021: 26.9%FY2022: 16.5%FY2023: 16.6%FY2024: 20.3%FY2025: 19.6%
3.2% YoY
EBITDA
$353MFY2021: $440MFY2022: $295MFY2023: $298MFY2024: $334MFY2025: $353M
5.7% YoY
Market cap
$5.9B
Employees
2,051
$658K revenue each
Net debt / EBITDA
—
AI in 10-K
1.5
mentions per 10K words

Takeover score 1 of 13

Fixable underperformance 0 of 7

Buyer economics 0 of 4

Catalysts 1 of 2

Financials

MetricFY2021FY2022FY2023FY2024FY2025YoYTrend
Revenue$1.3B$1.3B$1.3B$1.3B$1.3B 5.9% FY2021: $1.3BFY2022: $1.3BFY2023: $1.3BFY2024: $1.3BFY2025: $1.3B
Operating income$344M$207M$216M$258M$265M 2.6% FY2021: $344MFY2022: $207MFY2023: $216MFY2024: $258MFY2025: $265M
Net income$310M$184M$201M$262M$255M 2.6% FY2021: $310MFY2022: $184MFY2023: $201MFY2024: $262MFY2025: $255M
Operating cash flow$448M$319M$367M$327M$472M 44% FY2021: $448MFY2022: $319MFY2023: $367MFY2024: $327MFY2025: $472M
Capex$54M$48M$30M$30M$36M 21% FY2021: $54MFY2022: $48MFY2023: $30MFY2024: $30MFY2025: $36M
Stock-based comp$100M$115M$118M$120M$129M 7.3% FY2021: $100MFY2022: $115MFY2023: $118MFY2024: $120MFY2025: $129M
Buybacks$246M$530M$149M$160M$125M 22% FY2021: $246MFY2022: $530MFY2023: $149MFY2024: $160MFY2025: $125M
Dividends$89M$100M$103M$115M$127M 10% FY2021: $89MFY2022: $100MFY2023: $103MFY2024: $115MFY2025: $127M

Deal filings

None.

13D filers

FiledFilerFormStakeIntent
Feb 13, 2026Dolby DagmarSCHEDULE 13D/A36.0%Passive
Feb 3, 2025Dolby DagmarSCHEDULE 13D/A36.6%Passive
Nov 18, 2022Dolby DagmarSC 13D/A37.9%Active
Sep 28, 2020Dolby DagmarSC 13D/A36.6%Passive
Mar 19, 2020Dolby DagmarSC 13D/A36.7%Passive
Sep 24, 2019Dolby DagmarSC 13D/A1.6%Passive
Jul 3, 2019Dolby DagmarSC 13D/A38.0%Passive
May 7, 2019Dolby DagmarSC 13D/A38.0%Passive
Mar 13, 2019Dolby DagmarSC 13D/A38.4%Passive

Insider trading

Open-market buys, 12 mo
$0 · 0
Open-market sells, 12 mo
$15M · 38
Net
−$15M

Pay vs performance

No pay-versus-performance disclosure yet.